• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS® TAQSCREEN MPX TEST, VERSION 2.0 FOR USE ON THE COBAS S 201 SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GROUP M AND O RNA, HIV-2 RNA, HCV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS® TAQSCREEN MPX TEST, VERSION 2.0 FOR USE ON THE COBAS S 201 SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GROUP M AND O RNA, HIV-2 RNA, HCV Back to Search Results
Catalog Number 05969484190
Medical Device Problem Codes False Positive Result (1227); Incorrect, Inadequate or Imprecise Result or Readings (1535); Output Problem (3005)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/16/2021
Type of Reportable Event Malfunction
Event or Problem Description
The initial reporter alleged false reactive hiv results for two samples tested using the kit s201 t-scrn mpx v2.0 96t us-ivd assay on the cobas s201 instrument.On (b)(6) 2021, sample barcode (b)(4) was reported as reactive for hiv with a cycle threshold (ct) value of 43.06.On (b)(6) 2021, sample barcode (b)(4) was reported as reactive for hiv with a ct value of 34.4.Serology testing for both donor samples was negative.
 
Additional Manufacturer Narrative
The analysis was performed on a cobas s201 instrument (serial number: (b)(4)).The investigation determined that the cobas® taqscreen mpx v2.0 assay kit batch f31699 performed within specifications.However, the reported false reactive results were substantiated based on the provided data.A review of the sample data revealed that both samples generated relatively flat curves with cycle threshold (ct) values of 43.06 and 34.4, respectively.Serology testing for both donor samples was negative.Non-specific amplification could not be confirmed for sample (b)(4) due to the unavailability of ad plates.The device remains in operation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS® TAQSCREEN MPX TEST, VERSION 2.0 FOR USE ON THE COBAS S 201 SYSTEM
Common Device Name
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GROUP M AND O RNA, HIV-2 RNA, HCV
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
branchburg NJ 08876
Manufacturer (Section G)
ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG
1080 us highway 202 south
branchburg NJ 08876
Manufacturer Contact
natalie catton
9115 hague road
indianapolis, IN 46250
9253534412
MDR Report Key23098191
Report Number2243471-2025-03225
Device Sequence Number8766304
Product Code QHO
UDI-Device Identifier00875197004045
UDI-Public00875197004045
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
BL125459
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 09/19/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2021
Device Catalogue Number05969484190
Device Lot NumberF31699
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/30/2021
Initial Report FDA Received Date09/19/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-